Anzeige
Mehr »
Montag, 11.08.2025 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40YLD | ISIN: US09075F4046 | Ticker-Symbol: 2Y3
NASDAQ
08.08.25 | 21:59
2,890 US-Dollar
-1,37 % -0,040
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
BIONANO GENOMICS INC Chart 1 Jahr
5-Tage-Chart
BIONANO GENOMICS INC 5-Tage-Chart

Aktuelle News zur BIONANO GENOMICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
13.06.Bionano Genomics, Inc. - 8-K, Current Report16
15.05.Biggest stock movers Thursday: CSCO, BNGO, and more20
15.05.Bionano outlines $26M-$30M 2025 revenue target as strategic pivot drives higher gross margin7
14.05.Bionano Genomics stock rises on Q1 revenue beat7
14.05.Bionano Genomics, Inc. - 10-Q, Quarterly Report3
14.05.Bionano Genomics: Bionano Reports First Quarter 2025 Results and Highlights Recent Business Progress337SAN DIEGO, May 14, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the first quarter ended March 31, 2025. "The first quarter of 2025 represents...
► Artikel lesen
BIONANO GENOMICS Aktie jetzt für 0€ handeln
13.05.A Glimpse of Bionano Genomics' Earnings Potential2
02.04.Bionano Genomics, Inc. - S-8, Securities to be offered to employees in employee benefit plans4
01.04.Bionano Genomics outlines 2025 revenue guidance of $29M-$32M with strategic focus on utilization5
31.03.Earnings Snapshot: Bionano Genomics beats on topline in Q44
31.03.Bionano Genomics, Inc. - 10-K, Annual Report2
31.03.Bionano Genomics: Bionano Reports Fourth Quarter and Full-Year 2024 Results and Provides Revenue Outlook for 2025145SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2024 and revenue outlook...
► Artikel lesen
30.03.Bionano Genomics Q4 Earnings Preview3
28.03.What's Next: Bionano Genomics' Earnings Preview1
24.03.Bionano Genomics: Study Using OGM in Neural Tube Defects Reveals Previously Unreported Variants and Candidate Genes with Potential Links to the Devastating Birth Defect3
13.03.Bionano Genomics: Bionano Announces Publication Reporting First Use of OGM to Detect Chromoanagenesis, a Key Marker of Poor Prognosis in AML289In-Motion Webinar: Bionano will host a webinar featuring the study's lead author, Dr. Guilin Tang, who will discuss the study and its findings in detail, including a summary of the potential implications...
► Artikel lesen
21.02.Bionano Genomics, Inc. - 8-K, Current Report4
22.01.Bionano Genomics: Bionano Announces Effective Date of Reverse Stock Split517SAN DIEGO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO)(the "Company") today announced that it will effect a reverse stock split of its issued and outstanding common stock...
► Artikel lesen
10.10.24Bionano Genomics: Bionano Announces Preliminary 3Q 2024 Revenues and Cash406SAN DIEGO, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced select preliminary results for the quarter ended September 30, 2024. The Company now expects revenue...
► Artikel lesen
19 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1